triphenyltetrazolium has been researched along with Candida Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouchara, JP; Chabasse, D; Cimon, B; de Gentile, L; Le Clec'h, C; Symoens, F | 1 |
| Logotheti, M; Velegraki, A | 1 |
2 other study(ies) available for triphenyltetrazolium and Candida Infection
| Article | Year |
|---|---|
Prevalence of Candida ciferrii in elderly patients with trophic disorders of the legs.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Foot Dermatoses; Humans; Leg; Microbial Sensitivity Tests; Middle Aged; Nails; Onychomycosis; Oxidation-Reduction; Peripheral Vascular Diseases; Prospective Studies; Tetrazolium Salts; Toes | 1995 |
Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride.
Topics: Bacteriological Techniques; Candida; Candida albicans; Candidiasis; Diagnosis, Differential; Humans; Mycological Typing Techniques; Oxidation-Reduction; Species Specificity; Tetrazolium Salts | 1998 |